ATE414771T1 - Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen - Google Patents

Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen

Info

Publication number
ATE414771T1
ATE414771T1 AT95909825T AT95909825T ATE414771T1 AT E414771 T1 ATE414771 T1 AT E414771T1 AT 95909825 T AT95909825 T AT 95909825T AT 95909825 T AT95909825 T AT 95909825T AT E414771 T1 ATE414771 T1 AT E414771T1
Authority
AT
Austria
Prior art keywords
nucleic acids
transformed cells
galanin receptor
polypeptides
receptor
Prior art date
Application number
AT95909825T
Other languages
English (en)
Inventor
Brigitte Amiranoff
Estelle Habert-Ortoli
Isabelle Loquet
Original Assignee
Aventis Pharma Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Inst Nat Sante Rech Med filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE414771T1 publication Critical patent/ATE414771T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95909825T 1994-02-17 1995-02-14 Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen ATE414771T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401808A FR2716205B1 (fr) 1994-02-17 1994-02-17 Récepteur galanine, acides nucléiques, cellules transformées et utilisations.

Publications (1)

Publication Number Publication Date
ATE414771T1 true ATE414771T1 (de) 2008-12-15

Family

ID=9460177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909825T ATE414771T1 (de) 1994-02-17 1995-02-14 Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen

Country Status (12)

Country Link
US (2) US6447996B1 (de)
EP (1) EP0745122B1 (de)
JP (1) JP3989536B2 (de)
AT (1) ATE414771T1 (de)
AU (1) AU1814995A (de)
CA (1) CA2182621C (de)
DE (1) DE69535886D1 (de)
DK (1) DK0745122T3 (de)
ES (1) ES2317643T3 (de)
FR (1) FR2716205B1 (de)
PT (1) PT745122E (de)
WO (1) WO1995022608A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399325B1 (en) 1994-10-13 2002-06-04 Takeda Chemical Industries, Ltd. DNA encoding a galanin receptor
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
EP0819167A4 (de) 1996-01-24 2002-06-12 Synaptic Pharma Corp Dns codierend für galanin galr2 rezeptoren und deren verwendung
US6410686B1 (en) * 1996-06-05 2002-06-25 Bayer Corporation Galanin receptor 2 protein
SE9602822D0 (sv) 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
US6329197B2 (en) * 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
US6693182B1 (en) 1997-08-22 2004-02-17 Schering Corporation Mammalian galanin receptors
US20020137132A1 (en) * 2000-04-06 2002-09-26 Gabriel Vogeli Novel G protein-coupled receptors
JP2005507654A (ja) * 2001-08-27 2005-03-24 トゥラリック インコーポレイテッド 増幅した癌遺伝子およびそれらの癌への関与
US7582673B2 (en) * 2004-10-21 2009-09-01 High Point Pharmaceuticals, Llc Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015015A1 (en) * 1991-02-25 1992-09-03 Zymogenetic, Inc. Methods for detecting galanin antagonists
SE9101472D0 (sv) * 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist
EP0647275B2 (de) * 1992-06-23 2013-12-18 Mount Sinai School of Medicine Klonierung und expression von gonadotropinreleasing hormon

Also Published As

Publication number Publication date
CA2182621C (fr) 2011-06-14
US20030166895A1 (en) 2003-09-04
ES2317643T3 (es) 2009-04-16
CA2182621A1 (fr) 1995-08-24
US6447996B1 (en) 2002-09-10
DK0745122T3 (da) 2009-03-30
EP0745122B1 (de) 2008-11-19
FR2716205A1 (fr) 1995-08-18
JP3989536B2 (ja) 2007-10-10
DE69535886D1 (de) 2009-01-02
EP0745122A1 (de) 1996-12-04
PT745122E (pt) 2009-02-10
WO1995022608A1 (fr) 1995-08-24
JPH09510344A (ja) 1997-10-21
FR2716205B1 (fr) 1996-04-12
AU1814995A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
FI973055A (fi) Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi
DE60040274D1 (de) Verabreichung von nukleinsäuren und proteinen an zellen
DE69940431D1 (de) Brennstoffzellensystem und zellensteuerungsverfahren
BR9405507A (pt) Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
ATE422538T1 (de) Polypeptide mit alkaliner alpha-amylase-aktivität und für diese kodierende nukleinsäuren
ATE443719T1 (de) Interleukin-18 bindende proteine, deren herstellung und verwendung
DE60142072D1 (de) Positivelektrodenmaterial und dieses enthaltende zelle
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
ATE414771T1 (de) Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen
DE60031395D1 (de) Mikrobielle beta-glukuronidase gene, genprodukte und deren verwendungen
NO20000097D0 (no) Isolerte dendrittcellemembranproteingener
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
DE69837190D1 (de) Elektroden-Materialien zur Verwendung in Batterien,und Elektroden und Batterien, in denen diese verwendet werden
DE19983564T1 (de) Brennstoffzellen-System und Fahrzeug, das dieses verwendet
DE69033756T2 (de) Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen
BR9812138A (pt) Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta
ATE294861T1 (de) Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
DE69333284D1 (de) Polypeptide mit serotoninerger (5ht5a) rezeptor-aktivität, für sie kodierende nukleinsäuren und ihre verwendung
ATE297995T1 (de) Aussermembranproteine, ihre gene, und deren verwendung
ATE353103T1 (de) Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen
DE59807235D1 (de) Häcksler zum Zerkleinern von Halmgut
DE59813503D1 (de) Elektrodenmaterial
MX9204348A (es) Vector de adn para la transformacion de celulas de bacillus thuringiensis.
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0745122

Country of ref document: EP